The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Inhibition of LRRK2 Roc-COR GTPase
Study Rationale:
The LRRK2 protein is overactive in people with Parkinson’s and a mutation in the LRRK2 gene. Recent research shows LRRK2 may be overactive in a sporadic (cause unknown) Parkinson’s... -
Therapeutic Pipeline Program, 2019Development of a Novel TRPML1 Activator for Parkinson’s Disease
Study Rationale:
A primary cause of Parkinson’s disease is build-up of a toxic protein in specific neurons in the brain. There is evidence that in Parkinson’s disease the cellular machinery to clear... -
Epidemiological Parkinson's Risk Modifiers, 2019Association of Dietary Patterns with Parkinson’s Symptoms and Pathology
Study Rationale:
Currently there is no preventive treatment for Parkinson’s disease. Our recent analyses has indicated that healthy dietary patterns such as the MIND (Mediterranean-DASH Intervention... -
Research Grant, 2019Assessment and Monitoring of Neuromotor Function through Advanced Dynamic Pose Estimation
Study Rationale:
Parkinson’s disease (PD) begins well before movement symptoms appear, and many people have a long journey to diagnosis. No objective test for Parkinson’s exists. If we are able to... -
Improved Biomarkers and Clinical Outcome Measures, 2019International Validation of Two Non-motor Symptom Scales in Parkinson’s Disease
Study Rationale:
Non-motor Parkinson’s symptoms can fluctuate with dopaminergic medication effectiveness. Anxiety, sadness, lack of energy and fatigue are common symptoms during the off-medication... -
Target Advancement Program, 2019Identifying Protein Sequence of Potential Drug Target Synuclein Nitrase
Study Rationale:
We have found that alpha-synuclein nitration and aggregation — which may play a role in Parkinson’s disease — is catalyzed by an enzyme that we have termed synuclein nitrase. In this...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.